Ethyl 5-[4-[[(2S)-1-[[5-(4-tert-butylphenyl)-1,3,4-oxadiazol-2-yl]oxy]hexan-2-yl]amino]phenyl]-5-oxopentanoate
C31H41N3O5 — CID 158843509
Data last refreshed: (MolForge compound catalog, from PubChem)
About Ethyl 5-[4-[[(2S)-1-[[5-(4-tert-butylphenyl)-1,3,4-oxadiazol-2-yl]oxy]hexan-2-yl]amino]phenyl]-5-oxopentanoate
Ethyl 5-[4-[[(2S)-1-[[5-(4-tert-butylphenyl)-1,3,4-oxadiazol-2-yl]oxy]hexan-2-yl]amino]phenyl]-5-oxopentanoate (PubChem CID 158843509) has the molecular formula C31H41N3O5 and a molecular weight of 535.69 g/mol. Its IUPAC name is ethyl 5-[4-[[(2S)-1-[[5-(4-tert-butylphenyl)-1,3,4-oxadiazol-2-yl]oxy]hexan-2-yl]amino]phenyl]-5-oxopentanoate.
Molecular Properties
| Compound Name | Ethyl 5-[4-[[(2S)-1-[[5-(4-tert-butylphenyl)-1,3,4-oxadiazol-2-yl]oxy]hexan-2-yl]amino]phenyl]-5-oxopentanoate |
|---|---|
| PubChem CID | 158843509 |
| Molecular Formula | C31H41N3O5 |
| Molecular Weight | 535.69 g/mol |
| Exact Mass | 535.30 |
| IUPAC Name | ethyl 5-[4-[[(2S)-1-[[5-(4-tert-butylphenyl)-1,3,4-oxadiazol-2-yl]oxy]hexan-2-yl]amino]phenyl]-5-oxopentanoate |
| SMILES | CCCC[C@@H](COc1nnc(-c2ccc(C(C)(C)C)cc2)o1)Nc1ccc(C(=O)CCCC(=O)OCC)cc1 |
| InChI | InChI=1S/C31H41N3O5/c1-6-8-10-26(32-25-19-15-22(16-20-25)27(35)11-9-12-28(36)37-7-2)21-38-30-34-33-29(39-30)23-13-17-24(18-14-23)31(3,4)5/h13-20,26,32H,6-12,21H2,1-5H3/t26-/m0/s1 |
| InChIKey | WDXAIUQWYJMGJQ-SANMLTNESA-N |
| XLogP | 7.00 |
| TPSA | 103.55 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 15 |
| Heavy Atoms | 39 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 535.69 |
| LogP ≤ 5 | 7.00 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158843509 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.